Chief @ Precision Health at IHC
Lincoln Nadauld, M.D., Ph.D., is the Chief of Precision Health at Intermountain Healthcare. He founded the Intermountain Precision Genomics program with a vision of finding solutions to ease human suffering through precision medicine without increasing costs. He is the principal investigator of the HerediGene®: Population Study which is focused on discovering new connections between genetics and human disease.
Dr. Nadauld completed clinical training in Medical Oncology at Stanford University School of Medicine, where he also completed a postdoctoral fellowship in solid tumor genomics. He remains on the research faculty at Stanford, focusing on cancer genomics and personalized medicine. His work has been published extensively and even featured in a case study by Harvard Business Review, which discusses Intermountain Precision Genomics’ cutting-edge cancer care approach. His work was also recognized through the Utah Governor’s 32nd Annual Science Medal for Industry by honoring significant contributions to science and technology.
Dr. Nadauld is married with five children and enjoys attending their many activities and events, water sports, fishing, and other athletic pursuits.